Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus ...

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s (NYSE:LLY) olomorasib, in combination with Merck & Co. Inc.’s (NYSE:MRK) anti-PD ...

A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published Aug. 1 in Nature Medicine.

Rivals routinely cycles between different limited-time game modes, and the latest of these is the Hardcore Parkour mode. Hardcore Parkour is all about racing an opponent in an obstacle course, where ...

Roomba Max 705 Combo Provides heated mopping, 175x more suction power and first-of-its-kind cover protecting carpets from wet messes BEDFORD, Mass., July 22, 2025 /PRNewswire/ -- iRobot Corp. (NASDAQ: ...

The consumer’s thirst for AI-based applications is powering the ever-evolving electronics industry. Applications delivering higher levels of information in human language-like form, smarter at-home ...

Peluntamig targets DLL3 and CD47, potentially enhancing immune recognition and attack on cancer cells. The SKYBRIDGE study is a phase 1/2 trial assessing peluntamig's safety and efficacy in ...

Cabozantinib plus nivolumab and ipilimumab maintained a progression-free survival benefit at 45 months vs placebo in advanced kidney cancer. Final results from the phase 3 COSMIC-313 trial ...

Feb. 13, 2025 -- The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL). LBCL is a fast-growing cancer of B cells, a ...

More for You Barack Obama responds to Donald Trump's Russia "treason" threats US military releases footage it says shows live grenade being dropped from drone In-N-Out owner responds to backlash over ...

Induction chemotherapy followed by chemoradiotherapy improves five-year progression-free and overall survival rates in locally advanced cervical cancer patients. The induction chemotherapy regimen led ...

Artur is a copywriter and SEO specialist, as well as a small business owner. In his free time, he loves to play computer games and is glad that he was able to connect his professional career with his ...